Plain-English translation of NCT03753243 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing whether , a medicine that helps your immune system fight cancer, works better when combined with another hormone-blocking medicine called before prostate removal surgery. Men with high-risk prostate cancer will receive both medications for about 4 months, then have surgery. Researchers want to see if this combination can eliminate cancer cells before surgery happens.
High-risk prostate cancer is more likely to return or spread, even after surgery. This trial is exploring whether starting treatment before surgery—rather than waiting until after—might give patients a better chance of eliminating the cancer completely.
You likely qualify if…
You likely don't qualify if…
You would receive infusions of the first medication every 3 weeks and take a daily oral medication for about 4 months. You would also receive hormone therapy (standard care) to lower testosterone levels. During this time, you'll have regular clinic visits and blood tests to monitor how the medications are working and any side effects. After 4 months of treatment, you would have prostate removal surgery with removal of nearby lymph nodes, and doctors would examine the removed tissue to see if the cancer has been eliminated.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
United States